AJ Bell PLC (AJB.L) stock: key figures, P/E, revenue and dividend
Financials · United Kingdom · ISIN GB00BFZNLB60
AJ Bell PLC financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 269.00 m GBP | 317.00 m GBP |
| Gross profit | 0.00 GBP | 0.00 GBP |
| EBIT | 107.00 m GBP | 133.00 m GBP |
| Net income | 84.00 m GBP | 105.00 m GBP |
| Diluted EPS – continuing operations | 0.20 GBP | 0.26 GBP |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About AJ Bell PLC
AJ Bell plc, through its subsidiaries, operates investment platforms in the United Kingdom. The company offers AJ Bell Investcentre, which offers adviser needs and client service, easy-to-use functionality, and a comprehensive investment range at competitive prices; and AJ Bell, an investment platform. It also provides AJ Bell Touch, a mobile-focused platform service for financial advisers; AJ Bell Dodl, an investment platform that offers commission-free service; AJ Bell Investments, which offers investment management solutions through advisers and direct to customers; AJ Bell Securities for wealth management solutions. In addition, the company operates dealing and custody, media, and educational material. The company was founded in 1995 and is headquartered in Manchester, the United Kingdom.
More stocks
- Guangzhou Development Group Inc (600098.SS)
- Exosens SAS (EXENS.PA)
- STEVEN MADDEN, LTD. (SHOO)
- Lion Corp (4912.T)
- GRG Banking Equipment Co Ltd (002152.SZ)
- Apeloa Pharmaceutical Co Ltd (000739.SZ)
- L&K Engineering Suzhou Co Ltd (603929.SS)
- Slide Insurance Holdings, Inc. (SLDE)
- ITV PLC (ITV.L)
- Guangdong Zhongsheng Pharmaceutical Co Ltd (002317.SZ)
- Brederode SA (BREL.LU)
- Air France KLM SA (AF.PA)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.